← brief for 2026-11-03 · People & money

An open label, uncontrolled clinical trial of immunogenicity and safety of yellow fever vaccine in adults with chronic kidney disease as compared to immunocompetent

Article No results yet Peer reviewed

Key takeaways

This trial checked if the yellow fever vaccine is safe for people with kidney disease. It compared patients on dialysis and those not on dialysis with healthy adults. The study looked at side effects and how well the body made antibodies. It is a published report, but the abstract does not list the final numbers.

Who did this work

Amanda Caroline Ribeiro Sales (Universidade de São Paulo) · Camila de Melo Picone · Adriana de Souza Azevedo (Universidade de São Paulo) · Sheila Maria Barbosa de Lima (Fundação Oswaldo Cruz) · Anna Shoko Nishiya (Fundação Oswaldo Cruz) · Pedro Henrique de Mesquita Pacheco · Paula Keiko Sato (Instituto Butantan) · Camila Cristina Martini Rodrigues · Marta Heloísa Lopes · Amanda Nazareth Lara · Karina Takesaki Miyaji · Luiz Sérgio Azevedo

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-02
https://doi.org/10.1016/j.vaccine.2026.129314